Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 454.68
   
  • Change Today:
    $-2.01
  • 52 Week High: $513.76
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 433,699
  • Market Cap: $107,300m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 454.68
Change Today $ -2.01
% Change -0.44 %
52 Week High $513.76
52 Week Low $374.46
Volume 433,699
Shares Issued 235.99m
Market Cap $107,300m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 09-Mar-2026

Time Volume / Share Price
14:57 40 @ $454.68
14:57 79 @ $454.60
14:57 74 @ $454.60
14:57 40 @ $454.68
14:57 81 @ $454.60

Top of Page